PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective StudyMifen Chen, Yinghua Ji, Xiaodong Wang et al.|JCO Precision Oncology|2023Cited by 6
Phase III Trial Comparing XELOX Regimen (Oxaliplatin Plus Capecitabine) Versus EOX Regimen (Epirubicin, Oxaliplatin and Capecitabine) as First-Line Treatment for Advanced Gastric Cancer: The EXELOX TrialXiaodong Zhu, Weijian Guo, Mingzhu Huang et al.|SSRN Electronic Journal|2021Cited by 1